Company intelligence / Profile preview

Keraplast Technologies

Christchurch, Canterbury, New Zealand

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Keraplast manufactures and commercializes patented Functional Keratin protein ingredients with extensive scientific validation for efficacy in wound care, skin, hair, and wellness. They supply branded functional ingredients for health, nutrition, and personal care, with a major focus on commercialized applications in B2B contexts. No public clinical trials are reported, but substantial literature and data support efficacy in various applications[1][2].

Therapeutic areas: OtherDermatology
Modalities: ProteinRecombinant protein
Industry: Non-Drug Biotech

Partnerships

Global health, nutrition, and personal care companies (names not publicly disclosed)[2]Collaboration with New Zealand wool industry for raw material sourcing[1]

Beyond the preview

Go deeper on Keraplast Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keraplast Technologies.

Explore the full profile